Pregnant women who do not get enough sleep may be at higher risk of having children with neurodevelopmental delays, a new ...

We recently compiled a list of the 10 Undervalued Wide Moat Stocks to Buy According to Analysts. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the ...

As the global population ages, the demand for healthcare services surges, making the sector a promising avenue for long-term ...

Awardees were recognized for developing renewable lubricant base oils and ethyl acetate, more environmentally-friendly ...

New data show Talvey’s potential in multiple myeloma drug combinations. Elsewhere, AbbVie got more positive Parkinson’s drug ...

Patients with PAH saw significant improvement in pulmonary vascular resistance with use of MK-5475, an inhaled soluble guanylate cyclase stimulator.

With three months left in 2024, U.S. health care stocks are out of sick bay and up 12.3% on a year-to-date basis, as measured ...

The vaccine race: it was Brexit and Bingham what won it. There were good reasons for any member of the Tory Government to ...

Bayer says its drug candidate for chronic cough – eliapixant – has hit the mark in a phase 2b trial, putting it in hot pursuit of Merck & Co's gefapixant, which was filed for approval in March.

High Performance Liquid Chromatography Global Market Report 2024 – Market Size, Trends, And Forecast 2024-2033 ...

Pfizer has the FDA approval it was seeking for Prevnar 20, the latest update to its blockbuster pneumococcal vaccination franchise, keeping it one step ahead of a competing shot from Merck & Co.

First Human Procedure Performed at Salford Royal Hospital in Manchester, UK BARCELONA, Spain--(BUSINESS WIRE)--#BCI--INBRAIN ...